ZA915214B - Pharmaceutical treatment - Google Patents

Pharmaceutical treatment

Info

Publication number
ZA915214B
ZA915214B ZA915214A ZA915214A ZA915214B ZA 915214 B ZA915214 B ZA 915214B ZA 915214 A ZA915214 A ZA 915214A ZA 915214 A ZA915214 A ZA 915214A ZA 915214 B ZA915214 B ZA 915214B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical treatment
pharmaceutical
treatment
Prior art date
Application number
ZA915214A
Other languages
English (en)
Inventor
Martin David John Kenig
David John Kenig Martin
Richard Anthony Vere Hodge
Anthony Vere Hodge Richard
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA915214B publication Critical patent/ZA915214B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA915214A 1990-07-07 1991-07-05 Pharmaceutical treatment ZA915214B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015051A GB9015051D0 (en) 1990-07-07 1990-07-07 Pharmaceutical treatment

Publications (1)

Publication Number Publication Date
ZA915214B true ZA915214B (en) 1992-06-24

Family

ID=10678814

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915214A ZA915214B (en) 1990-07-07 1991-07-05 Pharmaceutical treatment

Country Status (17)

Country Link
EP (1) EP0538305B1 (xx)
JP (1) JP2764656B2 (xx)
KR (1) KR100196339B1 (xx)
AP (1) AP291A (xx)
AT (1) ATE151291T1 (xx)
AU (1) AU647807B2 (xx)
CA (1) CA2086756C (xx)
DE (1) DE69125610T2 (xx)
DK (1) DK0538305T3 (xx)
ES (1) ES2101747T3 (xx)
GB (1) GB9015051D0 (xx)
GR (1) GR3023611T3 (xx)
HK (1) HK1004527A1 (xx)
IE (1) IE912358A1 (xx)
IL (1) IL98749A (xx)
WO (1) WO1992000742A1 (xx)
ZA (1) ZA915214B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9323403D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
US6683084B1 (en) 1993-11-12 2004-01-27 Novartis International Pharmaceutical Ltd. Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
KR100382707B1 (ko) * 1994-12-12 2003-08-19 노파르티스 인터내셔널 파마슈티칼 리미티드 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
GB9504497D0 (en) 1995-03-07 1995-04-26 Smithkline Beecham Plc Pharmaceuticals
ES2203692T3 (es) * 1995-04-24 2004-04-16 Novartis International Pharmaceutical Ltd. Uso de trifosfato de (r)-penciclovir para la fabricacion de un medicamento para el tratamiento de enfermedades viricas.
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
DE3730541A1 (de) * 1987-09-11 1989-04-06 Hoechst Ag Verwendung bestimmter 6-mercaptopurine zur herstellung eines arzneimittels sowie verfahren zur herstellung des arzneimittels
AT388500B (de) * 1987-10-27 1989-06-26 Wellcome Found Antivirale 8-phenylxanthine

Also Published As

Publication number Publication date
JPH05507719A (ja) 1993-11-04
WO1992000742A1 (en) 1992-01-23
AU8103291A (en) 1992-02-04
AP9100290A0 (en) 1991-07-31
AU647807B2 (en) 1994-03-31
HK1004527A1 (en) 1998-11-27
GB9015051D0 (en) 1990-08-29
GR3023611T3 (en) 1997-08-29
IL98749A (en) 1995-03-30
ATE151291T1 (de) 1997-04-15
IE912358A1 (en) 1992-01-15
DE69125610T2 (de) 1997-11-20
DE69125610D1 (de) 1997-05-15
AP291A (en) 1993-12-29
IL98749A0 (en) 1992-07-15
JP2764656B2 (ja) 1998-06-11
ES2101747T3 (es) 1997-07-16
EP0538305A1 (en) 1993-04-28
EP0538305B1 (en) 1997-04-09
DK0538305T3 (da) 1997-10-13
CA2086756A1 (en) 1992-01-08
KR100196339B1 (ko) 1999-06-15
CA2086756C (en) 2003-04-08

Similar Documents

Publication Publication Date Title
AP9100340A0 (en) Pharmaceutical agents
GB9015051D0 (en) Pharmaceutical treatment
GB9025710D0 (en) Novel treatment
GB9024928D0 (en) Novel treatment
GB9000241D0 (en) Pharmaceutical use
GB9024926D0 (en) Novel treatment
GB9024925D0 (en) Novel treatment
GB9020697D0 (en) Treatment
GB9009388D0 (en) Treatment
ZA925931B (en) Medicinal treatment
IL102796A0 (en) Medicinal treatment
GB9000692D0 (en) Medicine
GB9021526D0 (en) Medicine
GB9020265D0 (en) Medicine
GB9022669D0 (en) Medicament
GB9024140D0 (en) Medical treatment
GB9026067D0 (en) Medical treatment
GB9014981D0 (en) New treatment
GB9003714D0 (en) Pharmaceutical process
GB9021412D0 (en) Pharmaceutical process
HU908009D0 (en) Medical cigarette-holder
GB9010298D0 (en) Novel treatment
GB9013268D0 (en) Novel treatment
GB9013910D0 (en) Novel treatment
GB9007734D0 (en) Novel treatment